Literature DB >> 2722276

The incidence and influence upon fertility of antisperm antibodies in seminal fluid following vasectomy reversal.

P L Matson1, S M Junk, J R Masters, J P Pryor, J L Yovich.   

Abstract

Seminal plasma samples from men undergoing vasovasostomy were analysed for antisperm antibodies using the indirect immunobead test. A pre-operative assessment showed antisperm antibodies of either IgA or IgG class to be present in 9/27 (33.3%) men. A significant increase (P less than 0.05) in the post-operative incidence of the antibodies was seen in the men who achieved patency (27/45, 60%) but not in those men for whom no sperm were seen in the ejaculate (4/10, 40%). After follow-up for a minimum of 1 year, conception rates for couples in which the male partner had achieved patency were similar in the groups with no antibodies detected post-operatively (12/18, 66.7%) or with IgA alone (2/3, 66.7%), but was reduced significantly in the presence of IgG (1/9, 11.1%; P less than 0.05) or IgA + IgG (3/15, 20.0%; P less than 0.01).

Entities:  

Keywords:  Antibodies--analysis; Biology; Data Analysis; Developed Countries; England; Europe; Examinations And Diagnoses; Family Planning; Genitalia; Genitalia, Male; Immunity; Immunologic Factors; Incidence; Laboratory Examinations And Diagnoses; Male Sterilization; Measurement; Northern Europe; Physiology; Research Methodology; Reversibility; Semen--analysis; Seminal Vesicles; Sterilization, Sexual; United Kingdom; Urogenital System; Vasectomy

Mesh:

Substances:

Year:  1989        PMID: 2722276     DOI: 10.1111/j.1365-2605.1989.tb01291.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  2 in total

1.  The Epidemiology of Anti-Sperm Antibodies Among Couples with Unexplained Infertility in North West Bank, Palestine.

Authors:  Anas Lotfi Yasin; Ahmad Lotfi Yasin; Walid Salim Basha
Journal:  J Clin Diagn Res       Date:  2016-03-01

Review 2.  Predictors of success in microsurgical correction of vasal and epididymal obstruction.

Authors:  A M Belker
Journal:  Curr Urol Rep       Date:  2001-12       Impact factor: 2.862

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.